Annual Cash & Cash Equivalents
$448.35 M
-$223.95 M-33.31%
December 31, 2024
Summary
- As of March 6, 2025, GDRX annual cash & cash equivalents is $448.35 million, with the most recent change of -$223.95 million (-33.31%) on December 31, 2024.
- During the last 3 years, GDRX annual cash & cash equivalents has fallen by -$492.76 million (-52.36%).
- GDRX annual cash & cash equivalents is now -53.72% below its all-time high of $968.69 million, reached on December 31, 2020.
Performance
GDRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$448.35 M
+$24.57 M+5.80%
December 31, 2024
Summary
- As of March 6, 2025, GDRX quarterly cash and cash equivalents is $448.35 million, with the most recent change of +$24.57 million (+5.80%) on December 31, 2024.
- Over the past year, GDRX quarterly cash and cash equivalents has increased by +$24.57 million (+5.80%).
- GDRX quarterly cash and cash equivalents is now -58.29% below its all-time high of $1.08 billion, reached on September 30, 2020.
Performance
GDRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GDRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.3% | +5.8% |
| 3 y3 years | -52.4% | -43.6% |
| 5 y5 years | +1621.1% | -43.6% |
GDRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.4% | at low | -52.4% | +5.8% |
| 5 y | 5-year | -53.7% | +1621.1% | -58.3% | +1621.1% |
| alltime | all time | -53.7% | +1621.1% | -58.3% | +1621.1% |
GoodRx Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $448.35 M(-33.3%) | $448.35 M(+5.8%) |
| Sep 2024 | - | $423.78 M(-19.3%) |
| Jun 2024 | - | $524.90 M(-1.6%) |
| Mar 2024 | - | $533.29 M(-20.7%) |
| Dec 2023 | $672.30 M(-11.2%) | $672.30 M(-15.4%) |
| Sep 2023 | - | $794.90 M(+4.3%) |
| Jun 2023 | - | $761.99 M(+0.1%) |
| Mar 2023 | - | $761.08 M(+0.5%) |
| Dec 2022 | $757.16 M | $757.16 M(+3.9%) |
| Sep 2022 | - | $728.79 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $730.54 M(-13.6%) |
| Mar 2022 | - | $845.43 M(-10.2%) |
| Dec 2021 | $941.11 M(-2.8%) | $941.11 M(+3.2%) |
| Sep 2021 | - | $912.02 M(+1.9%) |
| Jun 2021 | - | $894.70 M(-9.7%) |
| Mar 2021 | - | $990.46 M(+2.2%) |
| Dec 2020 | $968.69 M(+3618.6%) | $968.69 M(-9.9%) |
| Sep 2020 | - | $1.08 B(+749.0%) |
| Jun 2020 | - | $126.63 M(+386.1%) |
| Dec 2019 | $26.05 M(-24.7%) | $26.05 M |
| Dec 2018 | $34.60 M | - |
FAQ
- What is GoodRx Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GoodRx Holdings?
- What is GoodRx Holdings annual cash & cash equivalents year-on-year change?
- What is GoodRx Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GoodRx Holdings?
- What is GoodRx Holdings quarterly cash and cash equivalents year-on-year change?
What is GoodRx Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of GDRX is $448.35 M
What is the all time high annual cash & cash equivalents for GoodRx Holdings?
GoodRx Holdings all-time high annual cash & cash equivalents is $968.69 M
What is GoodRx Holdings annual cash & cash equivalents year-on-year change?
Over the past year, GDRX annual cash & cash equivalents has changed by -$223.95 M (-33.31%)
What is GoodRx Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GDRX is $448.35 M
What is the all time high quarterly cash and cash equivalents for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash and cash equivalents is $1.08 B
What is GoodRx Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, GDRX quarterly cash and cash equivalents has changed by +$24.57 M (+5.80%)